在复发性EBV阳性淋巴细胞恶性瘤中使用纳尼和瓦尔甘西克洛维尔的向治疗:一项1b/2期研究

Bradley Haverkos1, Onder Alpdogan2, Robert Baiocchi3

  • 1Division of Hematology, University of Colorado, Denver, CO.

Blood advances
|August 2, 2023
PubMed
概括

这项研究表明,结合纳胺和瓦尔甘克洛维尔是对艾普斯坦-巴尔病毒阳性淋巴瘤的有效治疗方法,为复发或耐药性疾病患者提供了希望.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K